US-based medical device company Nervonik has secured $52.5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) system. Amzak Health led the funding round, with ...
LOS ANGELES, April 27, 2026 /PRNewswire/ -- Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results